Functional and anatomical localization of mu opioid receptors in the striatum, amygdala, and extended amygdala of the nonhuman primate
- 20 April 2001
- journal article
- research article
- Published by Wiley in Journal of Comparative Neurology
- Vol. 433 (4) , 471-485
- https://doi.org/10.1002/cne.1154
Abstract
The subregional distribution of mu opioid receptors and corresponding G‐protein activation were examined in the striatum, amygdala, and extended amygdala of cynomolgus monkeys. The topography of mu binding sites was defined using autoradiography with [3H]DAMGO, a selective mu ligand. In adjacent sections, the distribution of receptor‐activated G proteins was identified with DAMGO‐stimulated guanylyl 5′(γ‐[35S]thio)triphosphate ([35S]GTPγS) binding. Within the striatum, the distribution of [3H]DAMGO binding sites was characterized by a distinct dorsal–ventral gradient with a higher concentration of binding sites at more rostral levels of the striatum. [3H]DAMGO binding was further distinguished by the presence of patch‐like aggregations within the caudate, as well as smaller areas of very dense receptor binding sites, previously identified in human striatum as neurochemically unique domains of the accumbens and putamen (NUDAPs). The amygdala contained the highest concentration of [3H]DAMGO binding sites measured in this study, with the densest levels of binding noted within the basal, accessory basal, paralaminar, and medial nuclei. In the striatum and amygdala, the distribution of DAMGO‐stimulated G‐protein activation largely corresponded with the distribution of mu binding sites. The central and medial nuclei of the amygdala, however, were notable exceptions. Whereas the concentration of [3H]DAMGO binding sites in the central nucleus of the amygdala was very low, the concentration of DAMGO‐stimulated G‐protein activation in this nucleus, as measured with [35S]GTPγS binding, was relatively high compared to other portions of the amygdala containing much higher concentrations of [3H]DAMGO binding sites. The converse was true in the medial nucleus, where high concentrations of binding sites were associated with lower levels of DAMGO‐stimulated G‐protein activation. Finally, [3H]DAMGO and [35S]GTPγS binding within the amygdala, particularly the medial nucleus, formed a continuum with the substantia innominata and bed nucleus of the stria terminalis, supporting the concept of the extended amygdala in primates. J. Comp. Neurol. 433:471–485, 2001.Keywords
This publication has 69 references indexed in Scilit:
- Effects of chronic cocaine administration on dopamine transporter mRNA and protein in the ratBrain Research, 1997
- Imaging of δ‐ and μ‐opioid receptors in temporal lobe epilepsy by positron emission tomographyAnnals of Neurology, 1997
- The Primate Substantia Nigra and VTA: Integrative Circuitry and FunctionCritical Reviews™ in Neurobiology, 1997
- Immunohistochemical localization of ?-opioid receptors in the central nervous system of the ratJournal of Comparative Neurology, 1996
- Repeated cocaine administration upregulates K and μ, but not δ, opioid receptorsNeuroReport, 1994
- The bed nucleus‐amygdala continuum in human and monkeyJournal of Comparative Neurology, 1991
- Muscarinic acetylcholine receptor‐stimulated binding of guanosine 5′‐O‐(3‐thiotriphosphate) to guanine‐nucleotide‐binding proteins in cardiac membranesEuropean Journal of Biochemistry, 1989
- Aggregations of granule cells in the basal forebrain (islands of Calleja): Golgi and cytoarchitectonic study in different mammals, including manJournal of Comparative Neurology, 1989
- Anatomy of CNS opioid receptorsTrends in Neurosciences, 1988
- Multiple opiate receptor in human brain: An autoradiographic investigationLife Sciences, 1983